KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 126 filers reported holding KALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,003,000 | +100000.0% | 24,200 | +142.0% | 0.00% | – |
| Q2 2022 | $3,000 | -78.6% | 10,000 | 0.0% | 0.00% | – |
| Q1 2022 | $14,000 | +16.7% | 10,000 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | -53.8% | 10,000 | 0.0% | 0.00% | – |
| Q3 2021 | $26,000 | -50.9% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $53,000 | -20.9% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $67,000 | -2.9% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $69,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,727,751 | $4,527,000 | 3.67% |
| RA Capital Management | 10,874,613 | $28,491,000 | 0.40% |
| ACT CAPITAL MANAGEMENT, LLC | 190,000 | $498,000 | 0.26% |
| Samsara BioCapital, LLC | 601,162 | $1,575,000 | 0.25% |
| Orbimed Advisors | 3,438,998 | $9,010,000 | 0.10% |
| Towercrest Capital Management | 122,500 | $321,000 | 0.06% |
| Knights of Columbus Asset Advisors LLC | 236,757 | $620,000 | 0.06% |
| Matisse Capital | 56,100 | $147,000 | 0.05% |
| Taylor Wealth Management Partners | 43,990 | $115,000 | 0.04% |
| SYMONS CAPITAL MANAGEMENT INC | 14,346 | $37,000 | 0.02% |